We serve Chemical Name:β-D-Fructofuranose CAS:53188-23-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:β-D-Fructofuranose
CAS.NO:53188-23-1
Synonyms:(2R,3S,4S,5R)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;D(-)-Fructose;D-Fructose;β-d-Fructose;D-(-)-Fructose;Levulose;Fructose [JAN];UNII:02T79V874P;Fructose, D-;(3S,4R,5R)-1,3,4,5,6-Pentahydroxy-2-hexanon;(3S,4R,5R)-1,3,4,5,6-Pentahydroxyhexan-2-one;Levugen;Fruit sugar;beta-D-fructofuranose;D-(-)-levulose;Fructose (JP15/USP);b-D-Fructose;DSSTox_CID_3081;arabino-2-Hexulose;D-Levulose;(3S,4R,5R)-1,3,4,5,6-Pentahydroxy-2-hexanone;δ-Fructose;Fructooligosaccharides;Fructose;β-δ-fructose;keto-D-fructose;D-fructofuranose;β-Fruit sugar;D-arabino-Hexulose;Furucton;β-D-arabino-Hexulose;β-Levulose;Laevosan;Laevoral;Fructose, furanose form;Fructosteril
Molecular Formula:C6H12O6
Molecular Weight:180.156
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:551.7±50.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.574
PSA:118.22000
Exact Mass:180.063385
LogP:-1.63
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2R,3S,4S,5R)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fructosteril physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Furucton Use and application,D-(-)-Fructose technical grade,usp/ep/jp grade.
Related News: With over 80 years of experience developing and manufacturing small molecules, UQUIFA has not only the knowledge and tools to successfully execute transfer activities but also the track record of success with several crucial drug commercialization,” Gurnurkar says. tetramethyl 1,2,3,9-tetrahydrocyclopenta[c]quinolizine-6,7,8,9-tetracarboxylate manufacturers The group, after examining Soliris’ late-stage trial data, determined they’re highly certain it produces a small benefit to patients who are positive for anti-AChR antibodies, while there’s a “moderate certainty of a small or substantial net health benefit.” 10,11,12-trimethoxy-3-(methylthio)-7,8-dihydro-4H-benzo[4,5]heptaleno[1,10-cd]isoxazol-4-one suppliers In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis. cis-4-Brom-cyclohexanol vendor & factory.
